MERCK UNVEILS TRIPLE THREAT COVID-19 STRATEGY
… Merck is launching 3 COVID-19 business initiatives …

MERCK UNVEILS TRIPLE THREAT COVID-19 STRATEGY

Development of 2 vaccines and an oral antiviral agent are key elements in Merck’s COVID-19 business plans

Merck and Ridgeback Biotherapeutics LP Partnership

Merck and International Aids Vaccine Initiative (IAVI)

Merck goes all-in against COVID-19 and acquires Themis Bio

Merck is up for the challenge

Merck’s successful 2020 and future business strategy is well underway

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/